AGENUS INC — Director's Dealing 2013

Aug 2, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2013-08-01

Reporting Person: ARMEN GARO H (Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-01	Common Stock	J	3437	$3.84	Acquired	1595310	Direct
2013-07-10	Common Stock	J	87175	$3.75	Acquired	1131727	Direct
2013-07-10	Common Stock	J	460146	$3.75	Acquired	1591873	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	43900	Indirect

Footnotes

F1: Represents issuance of stock for payment of approximately 33% of Dr. Armen's salary for July 2013.

F2: Represents required distribution pursuant to the terms of the Garo Armen 2009 4 Year GRAT.

F3: Represents required distribution pursuant to the terms of the Garo Armen 2012 2 Year GRAT.

F4: Dr. Armen is trustee and has investment authority for the Garo Armen 2012 2 Year GRAT holding 39,854 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership therein. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership of his pecuniary interest therein.